Lucira Health (NASDAQ:LHDXQ – Get Rating) is one of 41 public companies in the “Diagnostic substances” industry, but how does it contrast to its rivals? We will compare Lucira Health to related businesses based on the strength of its valuation, risk, analyst recommendations, profitability, dividends, earnings and institutional ownership. Analyst Ratings This is a breakdown […]
Lucira Health (NASDAQ:LHDXQ – Get Rating) is one of 41 publicly-traded companies in the “Diagnostic substances” industry, but how does it contrast to its competitors? We will compare Lucira Health to related businesses based on the strength of its risk, dividends, institutional ownership, analyst recommendations, earnings, valuation and profitability. Volatility & Risk Lucira Health has […]
Lucira Health (NASDAQ:LHDXQ – Get Rating) is one of 41 public companies in the “Diagnostic substances” industry, but how does it compare to its rivals? We will compare Lucira Health to similar businesses based on the strength of its valuation, profitability, institutional ownership, dividends, earnings, analyst recommendations and risk. Profitability This table compares Lucira Health […]
Lucira Health (NASDAQ:LHDXQ – Get Rating) is one of 41 publicly-traded companies in the “Diagnostic substances” industry, but how does it weigh in compared to its competitors? We will compare Lucira Health to related businesses based on the strength of its institutional ownership, valuation, earnings, risk, profitability, dividends and analyst recommendations. Analyst Recommendations This is […]
Lucira Health (NASDAQ:LHDXQ – Get Rating) is one of 41 publicly-traded companies in the “Diagnostic substances” industry, but how does it weigh in compared to its rivals? We will compare Lucira Health to related companies based on the strength of its risk, analyst recommendations, dividends, institutional ownership, valuation, earnings and profitability. Earnings and Valuation This […]